Large-scale testing (Phase 3)Looking for participantsNCT05125302
What this trial is testing
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Who this might be right for
Migraine
AbbVie 1,059